HIGHLIGHTS
- who: Puck E. Brons et al. from the Department of Gynecologic Oncology, Erasmus MC Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands have published the paper: Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review, in the Journal: Cancers Cancers 2022, 14, 2022, 573414, x of /2022/
- what: The tumor marker u2018cancer 125` (CA-125) plays a role in the management of women with advanced stage ovarian This study aims to describe the predictive value of pre-treatment CA-125 level and the reduction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.